Nordic Life Science
AMRA Medical has received FDA clearance for AMRAÒ Profiler, now available for use in a clinical setting in the US. AMRAÒ Profiler is indicated for use as a magnetic resonance
On December 7, Professor Reuss, from the University of Stuttgart, received the Novozymes Award for Excellence in Biochemical and Chemical Engineering 2018. “We are awarding Matthias Reuss for his ground-breaking contribution to
Through the new partnership AstraZeneca will become a Knowledge Partner to Chalmers Ventures and selected startups from Chalmers Venture’s portfolio will get the opportunity to receive counselling from AstraZeneca’s mentor
The company reports that a collaboration agreement with the Centre for Skin Sciences (CSS) at University of Bradford, UK, has been signed. The aim is to combine in vitro experiments with the
AstraZeneca announces a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of
The new integrated drug discovery alliance’s goal is to generate new leads against innovative targets for a range of dermatological conditions and initially runs for two years. The collaboration leverages Evotec’s
Sponsored Content
Drug & Device development
All patients in the company’s phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of the trial and no dose limiting toxicities (DLTs) were
Nordic Nanovector announces that updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin (177Lu-lilotomab-satetraxetan) in patients with relapsed/refractory indolent non-Hodgkin’s lymphoma (R/R iNHL) have been presented in
The company has presented a comprehensive analysis of monotherapy data from its BGBC003 clinical trial (NCT02488408) with selective AXL inhibitor bemcentinib in patients with relapsed/refractory Acute Myeloid Leukaemia (AML) or
The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with
LIDDS adds two major university clinics in Lithuania to its ongoing Phase IIb study, the National Cancer Institute in Vilnius and the University Clinic of Kaunas. The two clinics are
The company has announced new data from the CERTiFy (CERAMENT Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). “Successfully completing the ground-breaking CERTiFy study, to demonstrate
Sponsored Content
AMRA Medical has received FDA clearance for AMRAÒ Profiler, now available for use in a clinical setting in the US. AMRAÒ Profiler is indicated for use as a magnetic resonance
Latest news
All patients in the company’s phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of the trial and no dose limiting toxicities (DLTs) were
Our region is filled with life science activity. We take a closer look at what´s going in our Nordic cities when it comes to life science efforts, progress and challenges.
In focus – Nordic cities
Nordic Life Science
The latest clinical trials
All patients in the company’s phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of the trial and no dose limiting toxicities (DLTs) were
Nordic Nanovector announces that updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin (177Lu-lilotomab-satetraxetan) in patients with relapsed/refractory indolent non-Hodgkin’s lymphoma (R/R iNHL) have been presented in
The company has presented a comprehensive analysis of monotherapy data from its BGBC003 clinical trial (NCT02488408) with selective AXL inhibitor bemcentinib in patients with relapsed/refractory Acute Myeloid Leukaemia (AML) or
The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with
LIDDS adds two major university clinics in Lithuania to its ongoing Phase IIb study, the National Cancer Institute in Vilnius and the University Clinic of Kaunas. The two clinics are
The company has announced new data from the CERTiFy (CERAMENT Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). “Successfully completing the ground-breaking CERTiFy study, to demonstrate
A1M Pharma announces that the Swedish Medical Products Agency has granted permission to start a clinical Phase I study of ROSgard – a drug candidate developed to prevent Acute Kidney
The company announces that the dosing of patients in its first trial PP-CT01, studying the safety and tolerability of XEN-D0501 in patients with type 2 diabetes, was completed. XEN-D0501 is
Swedish ExpreS2ion Biotech Holding AB announces that The Jenner Institute of the University of Oxford have presented positive results from its Phase I/IIa clinical studies with their RH5.1 bloodstage malaria
The latest research news from the Nordic region
Science Article
On December 7, Professor Reuss, from the University of Stuttgart, received the Novozymes Award for Excellence in Biochemical and Chemical Engineering 2018. “We are awarding Matthias Reuss for his ground-breaking contribution to
Highly Cited Researchers from Clarivate Analytics is an annual list recognizing leading researchers in the sciences and social sciences from around the world and this year, Jaakko Kaprio and Samuli
It is once again time to honor extraordinary scientific discoveries. And this year, three of the Prizes have important life science applications, including cancer immunotherapy, eye operations and the production of new
According to a Nordic study the use of a new class of drugs in the treatment of type 2 diabetes, so called SGLT2 inhibitors, are linked to a twofold increased
He Jiankui, a genome-editing researcher at the Southern University of Science and Technology of China in Shenzhen, claims to have impregnated a woman with embryos that had been edited to disable
Professor Jan Holmgren at the University of Gothenburg is one of this year’s recipients of Prince Mahidol’s Award in Public Health. Prince Mahidol’s Award in Public Health is being awarded